Technology and products: cancer: Quest Diagnostics
Article Abstract:
Teterboro, NJ-based Quest Diagnostics Inc. is launching a new service to perform high-risk human papillomavirus (HPV) DNA testing for women with inconclusive results on their ThinPrep Pap Test for cervical cancer or its precursors.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Immunoassay: NMP179 may reduce uncertainty of mildly abnormal pap smears
Article Abstract:
Matritech's new test (NMP179) may reduce the uncertainty, apprehension and cost associated with millions of mildly abnormal Pap smears, according to a new report.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Neopath: Neopath's Autopap System succeeds in Kaiser Permanente clinical study
Article Abstract:
The Neopath AutoPap System significantly outperforms current pap tests, according to a study by Kaiser Permanente Medical Group.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 1999
User Contributions:
Comment about this article or add new information about this topic: